Norges Bank’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-633,780
| Closed | -$95.8M | – | 2222 |
|
|
2022
Q3 | $95.8M | Buy |
633,780
+29,701
| +5% | +$4.49M | 0.03% | 523 |
|
|
2022
Q2 | $88M | Buy |
604,079
+121,864
| +25% | +$17.8M | 0.02% | 564 |
|
|
2022
Q1 | $57.2M | Buy |
482,215
+79,483
| +20% | +$9.42M | 0.01% | 805 |
|
|
2021
Q4 | $55.5M | Buy |
402,732
+9,823
| +3% | +$1.35M | 0.01% | 884 |
|
|
2021
Q3 | $54.6M | Sell |
392,909
-21,514
| -5% | -$2.99M | 0.01% | 873 |
|
|
2021
Q2 | $40.2M | Buy |
414,423
+16,484
| +4% | +$1.6M | 0.01% | 1097 |
|
|
2021
Q1 | $27.2M | Sell |
397,939
-109,699
| -22% | -$7.5M | 0.01% | 1348 |
|
|
2020
Q4 | $43.5M | Buy |
507,638
+19,370
| +4% | +$1.66M | 0.01% | 1074 |
|
|
2020
Q3 | $31.7M | Sell |
488,268
-25,237
| -5% | -$1.64M | 0.01% | 1124 |
|
|
2020
Q2 | $37.5M | Buy |
513,505
+7,135
| +1% | +$522K | 0.01% | 1038 |
|
|
2020
Q1 | $17.2M | Buy |
506,370
+25,949
| +5% | +$883K | 0.01% | 1345 |
|
|
2019
Q4 | $26.2M | Buy |
480,421
+29,618
| +7% | +$1.61M | 0.01% | 1375 |
|
|
2019
Q3 | $18.8M | Hold |
450,803
| – | – | 0.01% | 1514 |
|
|
2019
Q2 | $19.7M | Buy |
450,803
+333,293
| +284% | +$14.6M | 0.01% | 1513 |
|
|
2019
Q1 | $6.05M | Buy |
+117,510
| New | +$6.05M | ﹤0.01% | 1916 |
|
|
2018
Q1 | – | Sell |
-50,000
| Closed | -$1.35M | – | 2204 |
|
|
2017
Q4 | $1.35M | Hold |
50,000
| – | – | ﹤0.01% | 2023 |
|
|
2017
Q3 | $1.87M | Hold |
50,000
| – | – | ﹤0.01% | 1976 |
|
|
2017
Q2 | $1.25M | Buy |
+50,000
| New | +$1.25M | ﹤0.01% | 2023 |
|